| Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426) |
|---|
| 08/27/2002 | US6441207 Method for making hydroxy-25-ene-vitamin D compounds |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/20/2002 | CA2073983C Novel vitamin d analogues |
| 08/15/2002 | US20020111503 Crystals of vitamin d derivatives and process for the preparation thereof |
| 08/13/2002 | US6433200 Antitumor and antirheumatic agents, high binding afinity to vitamin d receptors and weak hypercalcemic activity |
| 08/13/2002 | US6432936 Boiling in solvent; cooling; precipitation |
| 08/08/2002 | US20020107411 Such as 25-hydroxy-3-aminopropoxyvitamin D3 biotinamide; kits |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/01/2002 | US20020103173 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
| 08/01/2002 | US20020103172 Vitamin d3 derivatives |
| 07/25/2002 | US20020099039 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
| 07/24/2002 | CN1360572A Vitamin D3 Analogs |
| 07/18/2002 | WO2002006218A3 STABILIZED 1α-HYDROXY VITAMIN D |
| 07/18/2002 | US20020094972 24-hydroxy vitamin D derivatives |
| 07/11/2002 | US20020091109 Also for treating malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage. |
| 07/09/2002 | CA2191993C Novel synthesis of 19-nor-vitamin d compounds |
| 07/04/2002 | US20020087015 High intestinal calcium transport activity and relatively high bone calcium mobilization activity; treating osteoporosis, cancer, psoriasis |
| 07/03/2002 | EP1219599A1 Vitamin d derivatives having substituents at the 2 alpha-position |
| 07/03/2002 | CN1356981A Pharmaceutical compounds |
| 06/26/2002 | CN1086694C 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof |
| 06/25/2002 | US6410523 Vitamin D derivatives substituted at the 2beta-position |
| 06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
| 06/13/2002 | WO2001030751A3 USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP0944591B1 Vitamin d immunoassay systems |
| 06/04/2002 | US6399797 Vitamin D analogues |
| 06/04/2002 | US6399767 Intermediates for the synthesis of vitamin D and steroid derivatives and process for preparation thereof |
| 05/29/2002 | CN1351589A Vitamin D analogues and their pharmaceutical use |
| 05/23/2002 | WO2002005823A3 USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
| 05/22/2002 | EP1206448A1 Novel vitamin d analogues |
| 05/21/2002 | US6392071 Anticancer agents |
| 05/15/2002 | CN1348953A Technological process of purifying vitamin D3 |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 05/02/2002 | US20020052350 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
| 05/02/2002 | EP1200399A1 Vitamin d3 analogs |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/23/2002 | US6376480 Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 04/18/2002 | US20020045772 E.g., 2 beta-(2-iodoethyloxy)-1 alpha ,3 beta ,25-tris(triethylsilyloxy)cholesta-5,7-diene |
| 04/18/2002 | US20020045606 Esters of vitamin D3 and uses thereof |
| 04/17/2002 | EP0937038B1 Vitamin d analogues |
| 04/16/2002 | US6372926 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof |
| 04/16/2002 | US6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/04/2002 | WO2001002352A9 CRYSTALLINE 1α,24(S)-DIHYDROXYVITAMIN D2 AND METHOD OF PURIFICATION THEREOF |
| 04/03/2002 | EP1192129A2 Pharmaceutical compounds |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/28/2002 | WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 03/26/2002 | US6362350 Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof |
| 03/21/2002 | WO2001042205A3 Treatment of inflammatory bowel disease with vitamin d compounds |
| 03/20/2002 | CN1081184C Fluorinated vitamin D3 analogs |
| 03/19/2002 | US6359152 Treating secondary hyperparathyroidism by suppressing parathyroid activity; treating renal osteodystrophy while avoiding hyperphosphatemia; anticarcinogenic, -proliferative, -arthritic agents; autoimmune diseases |
| 03/19/2002 | US6359012 Method for making 24(S)-hydroxyvitamin D2 |
| 03/19/2002 | US6358939 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 03/14/2002 | WO2002020021A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 03/14/2002 | US20020032340 Antitumor and antirheumatic agents, high binding afinity to vitamin D receptors and weak hypercalcemic activity |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/07/2002 | WO2001040177A3 Esters of vitamin d3 and uses thereof |
| 02/27/2002 | CN1079791C Vitamin D. analogues |
| 02/26/2002 | CA2057048C Vitamin d analogues |
| 02/21/2002 | WO2002014268A1 1-methyl-20-epivitamin d derivative |
| 02/20/2002 | EP1180035A1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3? |
| 02/14/2002 | WO2002012182A1 3-methyl-20-epi-vitamin d derivatives |
| 02/13/2002 | EP1178960A1 Vitamin d analogues and their pharmaceutical use |
| 02/05/2002 | CA2051418C Novel vitamin d analogues |
| 01/24/2002 | WO2002006218A2 STABILIZED 1α-HYDROXY VITAMIN D |
| 01/24/2002 | WO2002005824A1 USE OF 2α-METHYL-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
| 01/24/2002 | WO2002005823A2 USE OF 2-METHYLENE-19-NOR-20(S)-1α,25-DIHYDROXYVITAMIN D3 TO INCREASE BONE STRENGTH |
| 01/24/2002 | US20020010163 Pregnacalciferol derivatives and corresponding 5,6-trans isomers exhibit anti-progesterone activity and may be useful as antineoplastic, antifertility, antiproliferative, immunosuppressive or antiinflammatory agents |
| 01/24/2002 | CA2416187A1 Use of 2.alpha.-methyl-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase bone strength |
| 01/24/2002 | CA2414407A1 Stabilized 1.alpha.-hydroxy vitamin d |
| 01/23/2002 | EP1174424A1 3-methylated vitamin d derivatives |
| 01/23/2002 | EP1173463A1 Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation |
| 01/23/2002 | CN1078072C Use of 1 alpha, 24-dihydroxy vitamin D2 |
| 01/17/2002 | US20020006917 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/19/2001 | CN1076347C 25-hydroxy-16-one-26.28-bishomo-cholecalciferols |
| 12/18/2001 | US6331642 Vitamin D3 analogs |
| 12/18/2001 | CA2018769C Adduct-aldehyde and its use for the preparation of a vitamin-d compound |
| 12/13/2001 | US20010051738 Crystalline1alpha,24(S)-dihydroxyvitamin D2 and method of purification thereof |
| 12/13/2001 | US20010051617 18-substituted-19-nor-vitamin D compounds |
| 12/12/2001 | EP0806413B1 2-substituted vitamin d3 derivatives |
| 12/12/2001 | EP0503035B1 Novel 1alpha-hydroxy vitamin d4 and novel intermediates and analogues |
| 12/11/2001 | US6329538 Induce differentiation and inhibition of proliferation in various skin and cancer cell lines and useful for therapy of hyperproliferative skin diseases, such as, psoriasis, neoplastic diseases such as leukemia, breast cancer |
| 12/06/2001 | WO2001092221A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 12/05/2001 | CN1075809C Novel vitamin D analogues |
| 12/04/2001 | US6326503 Antitumor agents |
| 11/29/2001 | WO2001090061A1 5,6-trans-2-alkylvitamin d derivatives |
| 11/29/2001 | WO2000010548A3 19-nor-vitamin d3 compounds with calcemic activity |
| 11/29/2001 | EP1143949A3 19-nor-vitamin d3 compounds with calcemic activity |
| 11/13/2001 | US6316642 For therapy of osteoporosis and psoriasis, as anticancer agent |
| 11/08/2001 | US20010039359 Boiling ethyl formate, ethyl actate, and/or 2-propanol-hexane mixture as solvent under inert atmosphere, precipitating crystals with cooling |
| 10/31/2001 | DE10019861A1 Neues Synthesezwischenprodukt, seine mikrobiologische Herstellung und Verwendung zur Synthese von Vitamin D-Derivaten A new synthetic intermediate, its microbiological production and use for the synthesis of vitamin D derivatives |
| 10/30/2001 | US6310226 Vitamin D analogues |
| 10/25/2001 | WO2001079166A1 Vitamin d derivatives |
| 10/25/2001 | WO2001079165A1 Synthesis intermediate products for producing vitamin d derivatives |